← Leaderboards
Liya Yin
Northeast Ohio Medical University
$7,447,549
Attributed
$9,079,681
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,079,681 · 7
By mechanism
R01$8,012,517 · 5
R56$612,364 · 1
R15$454,800 · 1
Top collaborators
- William M Chilian4 shared
- Yanqiao Zhang4 shared
Most similar at Northeast Ohio Medical University
Same institution · by research overlap
- Yanqiao Zhang$17,285,691
- Charles K Thodeti$4,031,724
- Feng Dong$1,150,938
- Cody Juguilon$147,604
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCellsIn VivoBlood VesselsCoronaryMyocardial IschemiaMicrornasImpairmentIschemiaReportingPreventMortalityDiabetes MellitusHypertensionHeartMyocardialMeasurementEndotheliumEchocardiographyBiologyFluorescence ImagingKnockout MiceBlood FlowInterdisciplinary Approach
Grant awards (19)
Disruption of the Cardiac-Coronary Axis as a Mechanism of HFpEF$657,378
R01 · FY2025 · HL · contact PI
Insights into Coronary Microvascular Dysfunction in Diabetic Cardiomyopathy$638,872
R01 · FY2025 · HL · contact PI
Disruption of the Cardiac-Coronary Axis as a Mechanism of HFpEF$645,671
R01 · FY2024 · HL · contact PI
Insights into Coronary Microvascular Dysfunction in Diabetic Cardiomyopathy$601,812
R01 · FY2024 · HL · contact PI
Insights into Coronary Microvascular Dysfunction in Diabetic Cardiomyopathy$644,520
R01 · FY2023 · HL · contact PI
Insights into Coronary Microvascular Dysfunction in Diabetic Cardiomyopathy$612,364
R56 · FY2022 · HL · contact PI
Mechanisms of Impaired Coronary Collateral Growth$390,000
R01 · FY2021 · HL · contact PI
What mechanisms underlie coronary collateral growth?$422,471
R01 · FY2020 · HL
Mechanisms of Impaired Coronary Collateral Growth$390,000
R01 · FY2020 · HL · contact PI
What mechanisms underlie coronary collateral growth?$422,471
R01 · FY2019 · HL
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2019 · HL
Mechanisms of Impaired Coronary Collateral Growth$390,000
R01 · FY2019 · HL · contact PI
What mechanisms underlie coronary collateral growth?$422,471
R01 · FY2018 · HL
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2018 · HL
Mechanisms of Impaired Coronary Collateral Growth$390,000
R01 · FY2018 · HL · contact PI
What mechanisms underlie coronary collateral growth?$435,371
R01 · FY2017 · HL
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2017 · HL
Regulation of Lipid and Lipoprotein Metabolism by Nuclear Receptors$390,370
R01 · FY2016 · HL
Induction of coronary ateriogenesis by reprogrammed cells$454,800
R15 · FY2012 · HL · contact PI